Default Category
-
Product Portfolio Management at Genentech
Schulman, Kevin A; Gresh, JamieCase HBS-317012-EFinanceGenentech, long the darling of the biotechnology industry, was acquired by Swiss pharmaceutical company Roche in 2009. The combined company retains the name Genentech in the US, but must now move to achieve the promises made at the time of this merger-to build from made Genentech great. One of the key tasks for Genentech CEO Ian Clark and CFO Ashraf Hanna was to implement a new portfolio management process for the combined entity. This case explo...Starting at €8.20
-
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
Schulman, Kevin A; Moodley, Sashidaran; Vasudevan, AnantCase HBS-317103-EEntrepreneurshipPharmAccess is an Amsterdam based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the public sector have the unintended consequence of crowding-out capital formation in the private sector. PharmaAccess is working to crowd-in funding instead through the development of a...Starting at €8.20
-
Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery
Schulman, Kevin A; Leya, Gregory; Beveridge, ChristianaCase HBS-317106-EStrategyKaiser Permanente (KP) is the largest managed care organization in the US with over 10 million members. KP evolved from a pre-payment or capitation model that focuses the organization around the efficiency of care and the health of the population it serves. This financial model is in stark contrast to the fee-for-service payment model for other health care organizations. Given the epidemic of obesity in the US, KP is facing an enormous potential ...Starting at €8.20
-
Creditor Activism in Sovereign Debt: Argentina vs. Holdout Investors (B)
Alfaro, Laura; Toshniwal, Gaurav; White, HilaryCase HBS-715017-EEconomicsStarting at €5.74
-
Renegotiating NAFTA
Alfaro, Laura; Sheldahl-Thomason, HavilandCase HBS-318143-EKnowledge and CommunicationStarting at €8.20
-
China: Flotar o no Flotar (B) Calendario de cambios relevantes del Renminbi chino
Alfaro, Laura; Di Tella, Rafael; Vogel, Ingrid; Kim, Renee; Russell, WilliamCase HBS-707S11EconomicsEl 21 de julio, 2005, China revaluó su tipo de cambio cuasi-fijo década de duración de aproximadamente 8,28 yuanes por dólar EE.UU. un 2,1% a 8,11% y, al mismo tiempo, introdujo un sistema de tipo de cambio más basado en el mercado. Muchos analistas y economistas se mostraron decepcionados con lo que consideraban un cambio muy pequeño y pidieron una mayor flexibilidad en el tipo de cambio dólar-yuan EE.UU.. Proporciona una línea de tiempo de más ...Starting at €5.74
-
The U.S. Shale Revolution: Global Rebalancing
Alfaro, Laura; Vietor, Richard H.K.Case HBS-717056-EEconomicsThe American shale revolution has upended oil and gas markets for nearly a decade...Prices have risen then plunged, production has surged and then waned, LNG has boomed and technology and productivity have improved. U.S. energy policy, under the Obama administration,authorized a handful of gas exporters, despite pressure from domestic chemical and utility interests, and approved oil exports for the first time in 40 years. Environmental issues and...Starting at €8.20
-
Latam Airlines and COVID-19: Seeking Bankruptcy Protection in the United States
Alfaro, Laura; Larrain, Mauricio; Vilches, Carlos; Jeong, SarahCase HBS-321027-EEconomicsOn May 26, 2020, Latam Airlines became the largest airline in the world to be driven to bankruptcy by COVID-19. With a complex debt structure and international investor composition, the company decided to file for bankruptcy protection in the United States, which offered a more flexible reorganization procedure than the local bankruptcy process. After the filing announcement, the company reached an all-time-low stock market valuation. Some expert...Starting at €8.20
-
Verily Life Sciences and Machine Learning
Schulman, Kevin A; Ho, KevinCase SGSB-SM335-EStrategyVerily Life Sciences, an independent subsidiary of Alphabet, Inc., set out to harness machine learning in the health care field. The company sought partnerships with academic research institutions, legacy life sciences companies, and hospitals and health systems to develop tools to collect and organize health data, with the goal of creating platforms that utilized the insights from that data to enhance patient care. The case study discusses these...Starting at €8.20
-
The U.S. Current Account Deficit (Spanish version)
Alfaro, Laura; Di Tella, Rafael; Vogel, Ingrid; Kim, Renee; Jeong, Sarah; Johnson, MatthewCase HBS-706S24EconomicsInvestors and policymakers throughout the world were confronted with the risk of painful economic consequences arising from the large U.S. current account deficit. In 2007, the U.S. current account deficit was $731 billion, equivalent to 5.3% of GDP. The implications of the deficit were debated with intensity. At one extreme, it was argued that large deficits would eventually resolve themselves smoothly, even if they persisted for many more years...Starting at €8.20